Medicine, Medical Oncology
-
-
Administers Grant
-
(R21) Microfluidic Droplet Organoids to Decipher the Tumor Heterogeneity in CRC of African Ancestry
-
2014 Gertrude B. Elion Mentored Medical Student Research Award
-
3D Biology Signatures defined by Nanostring Max System
-
A Decision Aid with HRQL Assessment to Reduce Costs in the Treatment of NSCLC
-
A Novel Function for ALK4 in Suppressing Breast Cancer Progression
-
A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent or Persistent Endometrial Cancer
-
A Phase II, Open-label, Multicenter, Randomized Study of CDX-1401, a Dendritic Cell Targeting NY-ESO-1 Vaccine, in Patients with Malignant Melanoma Pre-Treated with Recombinant CDX-301, a Recombinant
-
A Retrospective Study to Evaluate the Clinical Effectiveness of the OmniSeq Immune Advance Test to Predict Response to Checkpoint Inhibitors
-
A phase Ii trial of Neoadjuvant Ipilimumab follwed by Melphalan (L-PAM) via isolated Limb infusion (ILI) for patients with unresectable In-transit Extremity
-
A study is to develop a retrospective database to study the PGDx TMB +MSI assay associated with clinical responses to immune checkpoint inhibitors (CPIs)
-
ABL-regulated transcriptional and epigenetic networks promote outgrowth of breast cancer metastases revealing novel therapeutic targets
-
AFT-42 Immune Cells
-
ALK-1 and Endoglin Signaling in Endothelial Cells
-
ANC Study Group
-
AR variant regulation during EMT and disease progression
-
Alex's Million Mile Unrestricted Grant
-
An IND-enabling Trial to Determine the Number and Volume of Injections Necessary for
Adequate Distribution Throughout Cancer Metastases and to Validate Poliovirus Receptor (CD155) Expression in
Prostate Cancer
-
An integrated physiology and genomics analysis to define molecular adaptations to diving
-
An integrated physiology and genomics analysis to define molecular adaptations to diving
-
Analysis of baseline blood samples from a clinical study evaluating TRC105 in metastatic renal cell carcinoma cancer patients
-
Ancestry-related RNA splicing and immune expression in metastatic breast cancer
-
Angiome Profiling of GY012
-
Anonymous Donation
-
Anti-PD1 in combination with an inhibitor of PCSK9 to increase MHC class I molecule expression on tumor cells as immunotherapy for NSCLC
-
Anti-Tumor Effects of locally and Systemically Administered EZN-2279 monotherapy in a murine model of Colorectal Carcinoma
-
Anti-VEGF in Tumors & Wounds: Efficacy vs Toxicity
-
Antiestrogenic Effects on Tumor Angiogenesis
-
Autologous Bone Marrow Tranplants In Breast/Ovarian Ca
-
Autologous Bone Marrow Transplantation In Breast And Ovari
-
Autologous Bone Marrow Transplantation-Breast And Ovarian
-
Autologous Bone Marrow Transplants In Breast/Ovarian Ca
-
Autologous Bone Marrow Transplants--Breast Ovarian Ca
-
Autologous Bone Marrow Transplants-Breast/Ovary Cancer
-
BAYER PROTOTYPE PROSTATE PROGRAM - 3 DAY PROGRAMMING
-
BMS Bladder and Prostate Practicum 2019
-
BMS PROTOTYPE LUNG PROGRAM - 3 DAY PROGRAMMING
-
Best Quality of Care from a Distance (BQal-D): Maintaining High Quality Care for Hormone Receptor Positive Metastatic Breast Cancer during the COVID Pandemic
-
Bioengineering Plastic-Degrading Microbes To Eliminate Plastic Waste
-
Biomarker Studies for Novel Anti-Cancer Agents
-
Blood Banking Sciences And Related Areas
-
Blood-based Biomarker Profiling for Regorafenib in Metastatic Colorectal Cancer
-
Blood-based Biomarker Profiling for TEW-7197
-
Blood-based Biomarker Profiling for TEW-7197
-
Bone Marrow Transplantation for Breast Cancer
-
CITN-07 A Phase II, Open-label, Multicenter, Randomized Study of CDX-1401, a Dendritic Cell Targeting NY-ESO-1 Vaccine, in Patients with Malignant Melanoma Pre-Treated with Recombinant CDX-301, a Recombinant Human Flt3 Ligand
-
CITN-09 A Phase II Study of MK-3475 in Patients with Advanced Merkel Cell Carcinoma (MCC)
-
CTOT - Cell Free DNA
-
Cancer And Leukemia Group B
-
Cancer And Leukemia Group B
-
Cancer And Leukemia Group B
-
Cancer Center Core Support Grant
-
Cancer and Leukemia Group B
-
Cancer and Leukemia Group B
-
Cancer and Leukemia Group B
-
Cardiovascular Impact of Near-complete Estrogen Deprivation for Breast Cancer
-
Characterization Of Genes For Human Type I Collagen
-
Characterizing the Genetic Landscape of Prostate Cancer in Young African American Men - HDRA
-
Chordoma Foundation Brachyury Mouse Model Project
-
Chordoma Genetically Engineered Mouse Model
-
Circulating DKK1 Levels: Biomarker Assay Development
-
Clinical Biomarker Study of the Tumor NLRP3 Inflammasome and its Role in Anti-PD-1 Immunotherapy Resistance
-
Combined breast MRI/biomarker strategies to identify aggressive biology
-
Comprehensive Cancer Center Core Support Grant
-
Comprehensive Cancer Center Core Support Grant
-
Comprehensive Cancer Center Core Support Grant
-
Comprehensive Sickle Cell Center
-
Comprehensive Sickle Cell Disease Center
-
Comprhensive Sickle Cell Center
-
Conditional lethality of copper and disulfiram as a therapeutic modality for prostate cancer
-
Control Of The Hematopoietic Development Program (Suppleme
-
Control Of The Hematopoietic Developmental Program
-
Control Of The Hematopoietic Developmental Programs
-
Cooperative Study Of Sickle Cell Disease
-
Cooperative Study-Clinical Course Of Sickle Cell Disease
-
Creation Of A Center In Molecular Hematology
-
DUMC AIDS Malignancy Program
-
Defining the molecular physiologic impacts of stress on beaked whale hypoxia tolerance: implications for behavioral response
-
Determining susceptibility loci in triple negative breast cancer using a novel pre-clinical model
-
Determining the Efficacy of Liposomal Gemcitabine in Patient Derived Xenografts (PDXs)
-
Determining the clinical efficacy and predictive biomarkers of mirvetuximab soravtansine (IMGN853) in folate receptor alpha (FRA) expressing, chemotherapy refractory triple negative breast cancer
-
Development and Validation of Novel Therapeutic Targets in Anal Cancer
-
Development of Circulating Molecular Predictors of Chemotherapy and Novel Hormonal Therapy Benefit in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC)
-
Development of an Organoid/MicroOrganoid Biobank with matching TILs (Tumor Infiltrating Lymphocytes) to Correlate Response to Therapy
-
Dexasome Based Immunotherapy of Lung Cancer
-
Discovering Novel Tumor-Reactive Antibodies in Pembrolizumab-Treated NSCLC
-
Discovery and validation of putative oncogenic ROS1 alterations in metastatic breast cancer
-
Dissecting ALK4 Function in Cancer Progression
-
DoD: PCRP Clinical Consortium: Duke University Clinical Research Site
-
Does Comparative Effectiveness Research Promote Rationing or Rational Cancer Care?
-
Does Cytoplasmic PELP1 Predict Resistance To Tamoxifen Chemoprevention?
-
Does NO mediate clinical anti-VEGF vascular effects
-
Dolphin Quest: An integrated comparative physiology and genomics approach to understand dolphin adaptation to hypoxia
-
Dolphin Quest: Scholars - An integrated comparative physiology and genomics approach to understand dolphin adaptation to hypoxia
-
Dr. Anders-Cancer Research
-
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
-
Duke-Unc Comprehensive Sickle Cell Center
-
Duke-Unc Comprehensive Sicle Cell Center
-
Duke/Unc Comprehensive Sickle Cell Center
-
Dumc Aids Malignancy Program
-
EISAI BREAST CANCER ADVANCED TRAINING
-
EMD Serono, Inc. Education Event
-
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
-
Elucidating the Role of T_RIII in Breast Carcinogenesis
-
Endoglin Regulates Biology and Signal Transduction in Vascular Smooth Muscle Cells
-
Endoglin Regulates Endothelial Survival and Capillary Tube Stability
-
Epigenetic Regulation of Neuroblast Differentiation
-
Epigenomic Reprogramming in Patient Derived Models of Colorectal Cancer
-
Erythrocyte Blood Group Antigens Regulated By In (Lu)
-
Erythrocyte Blood Group Antigens Regulated By In(Lu)
-
Erythrocyte Protein Antigens Regulated By In(Lu)
-
Erythrocyte Protein Antigens Regulated By In(Lu)
-
Erythrocyte Protein Antigens Regulated By In-Lu
-
Evaluating the Impact of PCSK9 on the Composition of the Tumor-Immune Microenvironment and Treatment Response to Immune Checkpoint Blockade in NSCLC
-
Evaluation of Tumor Infiltrating Lymphocytes in Resected Non Small Cell Lung Cancer
-
Examining the Role of Cholesterol Metabolites on the Estrogen Receptor Signaling Pathway
-
Exercise training to promote improved immune resilience in adults with chronic lymphocytic leukemia - a randomized control trial
-
Exploration of Tumor-Intrinsic NLRP3 Signaling Regulators
-
Fibulin-3 as a Novel Biomarker and Trget in the Breast Tumor Microenvironment
-
Function of TbRIII as a BMP Co-receptor in Human Cancer
-
Genetic Analysis of Hereditary Macrothrombocytopenias
-
HSP70-TLR4-mediated MDSC Recruitment as an Adaptive Resistance
-
IL-6 in PDIGREE (AO31704)
-
IPA - Bradley Hintze
-
IPA - David Alcorta
-
IPA - David Alcorta
-
IPA - Sufeng Li
-
IPA - Sufeng Li
-
IPA - Sufeng Li
-
IPA - Teresa C Day
-
IPA Enyu Ding
-
Identification and validation of plasma-based protein biomarkers for cediranib and olaparib
-
Identification and validation of plasma-based protein biomarkers for cediranib and olaparib
-
Identification and validation of plasma-based protein biomarkers for cediranib and olaparib in GY005, phase III
-
Identification of Genetic Determinates for Disparities in African American Patients with Non-Small Cell Lung Cancer
-
Identifying novel CRM1 inhibitor combination therapies to treat sarcomas
-
Immune correlates of immunotherapy responses in renal cell carcinoma
-
Immune signatures in metastatic colorectal cancer
-
Immunotherapy to treat Triple Negative Breast Cancer Brain Metastases
-
In Vitro Fertilization Outcomes in Women Diagnosed with Cancer
-
Integrated Program for Persons with Hemostatic Disorders
-
Integrated analysis of a NLRP3-dependent adaptive resistance mechanism to pembrolizumab immunotherapy in advanced gastroesophageal cancer
-
Interactions between SERMs, Soy and Black Cohosh
-
International Retrospective Collaborative Analysis of the Impact of Ablative Therapy Directed to the Local Tumor and/or Metastases for Patients with Oligometastatic Prostate Cancer¿
-
Interrogating Race-related Alternative Splicing Variation in Metastasis
-
Investigating Oncogenic Signaling Pathways that Drive Wnt Ligand-mediated Immune Tolerance in Melanoma
-
Investigating the Combination PORCN Inhibitor, ETC-159, and Checkpoint Inhibitor Immunotherapy in Pre-Clinical Cancer Models
-
Investigating the Immunotherapeutic Properties of the DKK1 Antibody, DKN-01, in Pre-Clinical Models of Melanoma
-
Investigating the Impact of TPST-1120 PPAR ¿ Inhibition on Anti-PD-1 Antibody Immunotherapy Efficacy in Pre-Clinical Melanoma Models
-
Investigating the Role of EMT-mediated Dendritic Cell Tolerization in Checkpoint Inhibitor Resistance
-
Investigating the Role of a Novel Dendritic Cell Subset within Sentinel Lymph Node Tissues in Immune Evasion and Melanomagenesis
-
Investigation of TEW-7197 in Combination with Immune Checkpoint Inhibition in the BRAFV600E-PTEN-/- Melanoma Model
-
Investigation of a Novel PD-L1:NLRP3 Inflammasome Activation Pathway as a Driver of Metastatic Recurrence
-
Investigation of the FZD8-Fc Wnt Ligand Antagonist and the Fzd Receptor Monoclonal Antibody in Combination with Immune Checkpoint Blockade in Pre-Clinical Melanoma, Non-Small Cell Lung Cancer, and Col
-
KCNK9 Imprinting in Breast Cancer Progression and Metastasis
-
Kidney Cancer Research Program Clinical Consortium Duke University Clinical Trial Site
-
MSI in mCRC
-
Marine Mammals Point the Way Toward New Therapies to Prevent Hypoxia
-
Markers of short term breast cancer risk in FNA
-
Measurement of Hypoxia in Non-Small Cell Lung Carcinoma
-
Melanoma-mediated Dendritic Cell Tolerization and Immune Evasion
-
Membraine Abnormalities In Pnh
-
Membrane Abnormalities In Pnh
-
Membrane Abnormalities In Pnh
-
Mentored Oriented Research Career Development Award
-
Merck Sharp & Dohme Corp. Study Agreement
-
Metabolic Reprogramming of Dendritic Cell-based Cancer Vaccines to Enhance Anti-Tumor Immunity
-
Methods To Improve Camptothecan-Based Chemotherapy
-
Micro-Organospheres Drug Screen to Lead Care (MODEL) Platform to Guide Cancer Care
-
Molecular Analysis Of Bpv-1 Replication
-
Molecular Dissection and Immune Characterization of Breast Cancer Brain Metastases to Predict Outcomes and Reveal Novel Therapeutic Strategies
-
Molecular Targets Of The In (Lu) Gene
-
Molecular Targets Of The In Lu Gene
-
Molecular Targets Of The In(Lu) Gene
-
Mountaineer Biomarker Study: A Phase II, Open Label Study of Tucatinib Combined with Trastuzumab in Patients with HET2+ Metastatic Colorectal Cancer.
-
Multispectral Imaging Flow Cytometer Core
-
New Clinical Biomarker for Cancer--Wound Angiogenesis
-
New strategies to improve drug development for carcinoid tumors
-
Nimh Clinical Training
-
Nitric Oxide And Severe Malaria
-
Non-CME Educational Oncological Immersion Experience
-
Noninvasive Monitoring Glutathione Metabolism in Tumors
-
Novartis Breast Cancer Practicum
-
Novel Roles for Endoglin in TGF-b Signaling
-
Overcoming Anti-PD-1 Resistance in Melanoma by Targeting Immunologic Mediators of the Gli2 Pathway
-
PRACTICUM - SANOFI 3 DAY DISEASE STATE TRAINING PROGRAM (PROSTATE, STEM CELL TRANSPLANT,LEUKEMIA /LYMPHOMA)
-
Palliative Oxygen for the Relief of Breathlessness
-
Phase I/II Trial of ZD1839 and Celecoxib in Ex-Smokers
-
Phase II Pilot Trial of an Indoleamine 2, 3,diosygenase -1 ( IDO1) Inhibitor (INCBO24360) Plus a Multipeptide Melanoma Vaccine ( MELTAC 12.1 ) in Patients with Advanced Melanoma
-
Phase II Pilot Trial of an Indoleamine 2, 3,diosygenase -1 (IDO1) Inhibitor (INCBO24360) Plus a Multipeptide Melanoma Vaccine (MELTAC 12.1) in Patients with Advanced Melanoma (CITN-04)
-
Phosphatidylinositol-Anchored Blood Group Antigens
-
Pilot Study for Feasibility of Next Generation Sequencing for Detection of Lung Cancer ALK and ROS1 Mutation.
-
Plasma Angiome and Serum Androgens as Predictors of Overall Survival in Metastatic Prostate Cancer
-
Plasma Angiome and Serum Androgens as Predictors of Overall Survival in Metastatic Prostate Cancer
-
Platelet Studies In Thrombocytopenia
-
Preclinical and Human Correlative Studies of a Novel Bruton Tyronsine Kinase Inhibitor in Pancreatic Cancer
-
Predicting patient-specific responses to personalize androgen deprivation therapy for prostate cancer
-
Profiling the Adenosine Axis in Metastatic Colorectal Cancer
-
Prostate Cancer Outcomes: An International Registry
-
Prostate Cancer, Stem Cell Transplantation and Leukemia/Lymphoma Practicum
-
RAP-041 mediated modulation of intratumoral immune cell subpopulations in vivo and effect of combination treatment with anti-PD1 monoclonal antibody
-
RAR-Beta Mediated Apoptosis in Breast Cancer Cells
-
Race-Related Alternative Splicing: Novel Targets in Prostate Cancer
-
Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer
-
Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer
-
Race-related germline genetic variation and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer
-
Real-world patterns of care for CDK4/6 inhibitor treatment of Metastatic Breast Cancer
-
Research Training In Cancer Biology And Therapy
-
Research Training In Cancer Biology And Therapy
-
Research Training in Cancer Biology and Therapy
-
Retrospective analysis of docetaxel in castration sensitive setting
-
Role Of C-Kit In Early Hematopoiesis
-
Role for TbetaRIII Shedding in the Tumor Microenvironment
-
Role of ALK4 in Pancreatic Cancer Progression
-
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology
-
Role of TGF beta Receptor III Localization in Breast Cancer Progression
-
Role of TbRIII in Regulating Motility and Invasion
-
Role of Tumor-mediated Innate Training in the Pathogenesis of Immune-related Adverse Events
-
Role of Type III TGF-b Receptor in Mediating Immunosuppression During Breast Cancer Progression
-
Role of Type III TGF-beta Receptor Shedding in Lung Cancer Initiation and Progression
-
Role of the Type III TGF-b Receptor in TGF-b Signaling
-
Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities
-
Role of the type III TGF-Beta Receptor in cancer Biology
-
Same
-
Same
-
Scholars in Marine Medicine: Mentored Research at the Nexus of the Marine Environment and Human Health.
-
Serum Biomarkers in Lymphoma
-
Sickle Cell Adhesion
-
Stroma Biology Identifies Heparin as a Differentiating Agent in Neuroblastoma
-
Structure-Function Relationships In Protectin (Cd59)
-
Structure-Function Relationships Of Protectin (Cd59)
-
TESARO LUNG AND ENDOMETRIAL CANCER PRACTICUM
-
TGFBI in the breast cancer microenvironment promotes TGF-B signaling to increase tumor progression
-
Tailored Information Materials About Brca1 Testing
-
Targeted Chemoprevention of Breast Cancer: From the Bench to Clinical Testing
-
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis
-
Targeting Calreticulin in Colorectal Cancer Liver Metastasis
-
Targeting Convergent Mechanisms of Therapy Resistance, Metastasis, and Immune Evasion with CBP inhibitors
-
Targeting Immunosuppressive Cancer Associated Fibroblasts and Immune Checkpoints in NSCLC
-
Targeting KRAS (G12C) Mutant in Colorectal Cancer
-
Targeting convergent mechanisms of castration resistant prostate cancer therapy resistance, metastasis, and immune evasion with AR-LDDs
-
Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer
-
Targeting the TK1 receptor in colorectal and lung PDX using CarT cell and Motorcar cell
-
Targeting the WNT/beta-catenin Pathway in Triple Negative Breast Cancer
-
Targeting the p38/Snail/PD-L1 axis in hormone-therapy resistance and metastasis
-
Tension-Stat3-miR-mediated metastasis
-
Testing the efficacy of AR degrading compounds in enzalutamide-resistant prostate cancer
-
The Contribution of Rare Variants in Familial Clustering of Prostate and Breast Cancer in African Americans
-
The Duke University Marine Laboratory Scholars Program: Enhancing mentored research experiences for undergraduates
-
The Role of HER2 Signaling Networks in Early Stage Breast Cancer Initiation and Resistance to Tamoxifen Prevention
-
The Role of Mutations in BRCA2 and Other Known and Novel Cancer Susceptibility Genes in Inherited Risk for Lethal Prostate Cancer - IMPACT
-
The Role of Stroma-derived Soluble TbetaRIII in Neuroblastoma
-
The Role of Type III TGF-beta Receptor in ALK1-mediated Tumor Angiogenesis
-
The Role of Type III TGF-beta Receptor in the Fibrotic Tumor Stroma
-
The prevalence of MET gene amplification in metastatic colorectal cancer
-
The role of Claudin-2 in metastatic colorectal cancer
-
The role of RalA in pancreatic tumorigenesis
-
Therapeutic Targeting of the TGF-beta Signaling Axis to Modulate the Tumor Immune Microenvironment and Enhance Melanoma Immunotherapy
-
Tissue Transglutaminase And Breast Cancer Biology
-
Tissue Transglutaminase And Breast Cancer Biology
-
Transfusion Medicine And Related Areas
-
Transfusion Medicine And Related Areas
-
Transfusion Medicine And Related Areas
-
Transfusion Medicine And Related Areas
-
Transfusion Medicine And Related Areas
-
Transfusion Trial To Prevent Platelet Alloimmunizations
-
Transfusion Trial To Prevent Platelet Alloimmunizations Cl
-
Tumor Infiltrating lymphocyte adoptive T cell therapy for NSCLC
-
Tumor-derived Exosome Induction of Dendritic Cell Tolerization
-
Type III TGF-beta Receptor as a Mediator/Reg. of Sign
-
Use Of Hydroxyurea In Patients With Sickle Cell Anemia
-
Vaccination with Regulatory T Cell Depletion
-
Validation of Prostate Cancer Stem Cell Model in First and Second Line Hormone Therapy
-
Wound Angiogenesis as a Biomarker for Tumor Angiogenesis
-
Yr5 Role Of Platelet-Derived Growth Factor In The Pathogen
-
same